Sarissa Capital Management LP Ironwood Pharmaceuticals Inc Transaction History

Sarissa Capital Management LP

$592 Million
Q2 2024

A detailed history of Sarissa Capital Management LP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Sarissa Capital Management LP holds 16,390,000 shares of IRWD stock, worth $65.9 Million. This represents 18.04% of its overall portfolio holdings.

Number of Shares

16,390,000

Previous 16,390,000 -0.0%

Holding current value

$65.9 Million

Previous $143 Million 25.14%

% of portfolio

18.04%

Previous 24.97%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $21.2 Million - $27.9 Million	2,350,000 Added 16.74%	16,390,000 $183 Million
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $4.71 Million - $6.16 Million	515,000 Added 3.81%	14,040,000 $145 Million
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $27.6 Million - $45.1 Million	3,218,000 Added 31.22%	13,525,000 $136 Million
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $1.68 Million - $2.86 Million	204,000 Added 2.02%	10,307,000 $137 Million
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $3.31 Million - $4.22 Million	385,000 Added 3.96%	10,103,000 $86.7 Million
Q2 2019 Aug 14, 2019	BUY	$9.8 - $12.89 $21.3 Million - $28 Million	2,175,800 Added 28.85%	9,718,000 $106 Million
Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $10.7 Million - $16.4 Million	1,289,900 Added 20.63%	7,542,200 $102 Million
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $22.5 Million - $46.5 Million	2,885,200 Added 85.69%	6,252,300 $64.8 Million
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $19.1 Million - $23.4 Million	1,717,100 Added 104.07%	3,367,100 $52 Million
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $20.1 Million - $24.1 Million	1,650,000	1,650,000 $24.7 Million

Others Institutions Holding IRWD

# of Institutions

247

Shares Held

171M

Call Options Held

11.2M

Put Options Held

28.5K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $616M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarissa Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sarissa Capital Management LP with notifications on news.

Account

Sarissa Capital Management LP Ironwood Pharmaceuticals Inc Transaction History